docetaxel anhydrous has been researched along with Colorectal Neoplasms in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (13.16) | 18.2507 |
2000's | 9 (23.68) | 29.6817 |
2010's | 18 (47.37) | 24.3611 |
2020's | 6 (15.79) | 2.80 |
Authors | Studies |
---|---|
Hao, YP; Liu, ZY; Ning, JF; Sun, X; Tang, ML; Zhou, L | 1 |
Chen, HC; Chen, SS; Dai, Z; He, YJ; Jin, DN; Jin, Q; Luo, XD; Wang, ZJ; Zhao, LX; Zhao, YL; Zhu, YY | 1 |
Han, R; Hao, Y; Hu, D; Liu, Q; Lu, Y; Peng, J; Qian, Z; Xiao, Y; Yuan, L | 1 |
Arias, FJ; Girotti, A; Gonzalez-Valdivieso, J; Rodriguez-Rojo, S; Santos, M; Schneider, J; Vallejo, R | 1 |
Agrawal, AK; Agrawal, S; Banach, J; Gamian, A; Makuch, S; Pielka, E; Pizon, M; Wietrzyk, J; Woźniak, M; Ziółkowski, P; Łuc, M | 1 |
Fabian, KP; Fujii, R; Hodge, JW; Padget, MR; Schlom, J | 1 |
Chu, D; Guo, J; Han, S; O'Driscoll, CM; Song, L; Sun, B; Sun, D; Wang, L; Xiao, F; Yu, Z; Zou, Y | 1 |
Chang, SY; Chin, YW; Heo, EY; Hong, EH; Jeon, SM; Kim, J; Ko, HJ; Kwon, BE; Lee, JY; Park, Y; Song, JH | 1 |
Andriana, BB; Matsuyoshi, H; Sato, H; Taketani, A | 1 |
Cicero, G; De Luca, R; Dieli, F | 1 |
Endo, K; Kuriyama, A | 1 |
Alomrani, AH; Ashour, AE; Badran, MM; Harisa, GI; Kumar, A; Yassin, AE | 1 |
Golmohammadzadeh, S; Hanafi-Bojd, MY; Jaafari, MR; Malaekeh-Nikouei, B; Mosallaei, N | 1 |
Beerling, E; Janssen, A; Medema, R; van Rheenen, J | 1 |
Ahuja, N; Azad, NS; Danilova, L; Delmas, A; Herman, JG; Pelosof, L; Yerram, SR | 1 |
Brock, MV; Fuks, F; Guo, M; Herman, JG; Li, Y; Wu, K; Yan, W; Yang, L; Yang, Y; Zhu, H | 1 |
Fan, R; Guo, G; Han, B; Luo, Y; Peng, X; Wang, Y; Wu, M; Zheng, Y; Zhou, L | 1 |
Brock, MV; Guo, J; Guo, M; Herman, JG; Linghu, E; Yang, Y; Zhan, Q; Zhang, B | 1 |
Barjat, H; Emmas, SA; Honndorf, VS; Pichler, BJ; Quintanilla-Martinez, L; Schmidt, H; Stahlschmidt, A; Wehrl, HF; Wiehr, S | 1 |
Fan, R; Gao, X; Guo, G; Li, X; Mei, L; Tong, A; You, C; Zhang, X; Zhou, L | 1 |
Hori, S; Seki, A | 1 |
Choi, HG; Kang, Y; Kim, IY; Kim, JA; Park, SY; Thapa, D | 1 |
Chen, J; Liu, B; Qian, X; Wang, T; Wei, J; Xie, L; Yu, L; Zou, Z | 1 |
Farsaci, B; Ferrone, S; Gameiro, SR; Garnett, CT; Hodge, JW; Palena, C; Tsang, KY | 1 |
Akiyama, T; Hirabayashi, Y; Hirai, T; Ikeda, M; Iki, K; Kubozoe, T; Matsumoto, H; Sadahira, Y; Tsunoda, T; Urakami, A; Yamamura, M; Yamashita, K | 1 |
Endo, Y; Fujiwara, T; Hioki, M; Ikeda, Y; Kagawa, S; Kishimoto, H; Sakai, R; Tanaka, N; Urata, Y | 1 |
Desai, K; Einstein, M; Fields, A; Goel, S; Goldberg, G; Macapinlac, M; Mani, S; Martin, R; Volterra, F; Wadler, S; Wong, B | 1 |
Boulikas, T; Erdmann, R; Fedier, A; Fink, D | 1 |
Geng, M; Ji, YB; Jiang, JS; Li, H; Lou, GY; Ma, T; Xi, WQ; Xia, HQ; YeE, ZB | 1 |
Bruntsch, V; Dirix, LY; Franklin, H; Kaye, SB; Le Bail, N; Pavlidis, NA; Smyth, JF; Sternberg, CN; ten Bokkel Huinink, WW; Wanders, S | 1 |
Abbruzzese, JL; Ajani, JA; Bready, B; Lassere, Y; Levin, B; Patt, Y; Pazdur, R; Soh, LT; Soo, E; Sugarman, S | 1 |
Rougier, P | 1 |
Andre, AM; Clark, TB; Conti, JA; Huang, Y; Kemeny, NE; Stockman, J | 1 |
Kobayashi, T; Maeda, Y; Okamoto, R; Omuro, Y; Sasaki, T; Takeda, N | 1 |
Blesch, K; Reigner, B; Weidekamm, E | 1 |
Prescott, LM | 1 |
Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H | 1 |
Sun, Y | 1 |
4 review(s) available for docetaxel anhydrous and Colorectal Neoplasms
Article | Year |
---|---|
Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Docetaxel; Drugs, Chinese Herbal; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids | 1995 |
[New combination therapies for gastrointestinal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colorectal Neoplasms; Docetaxel; Fluorouracil; Humans; Irinotecan; Leucovorin; Paclitaxel; Prognosis; Stomach Neoplasms; Survival Analysis; Taxoids | 2000 |
Clinical pharmacokinetics of capecitabine.
Topics: Antacids; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Food; Humans; Intestinal Absorption; Leucovorin; Liver Diseases; Paclitaxel; Protein Binding; Taxoids | 2001 |
4 trial(s) available for docetaxel anhydrous and Colorectal Neoplasms
Article | Year |
---|---|
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colorectal Neoplasms; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Oligonucleotides; Pancreatic Neoplasms; Prothrombin Time; Taxoids | 2006 |
Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paclitaxel; Taxoids | 1994 |
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids | 1994 |
Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Female; Humans; Male; Middle Aged; Paclitaxel; Taxoids | 1998 |
30 other study(ies) available for docetaxel anhydrous and Colorectal Neoplasms
Article | Year |
---|---|
Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Colorectal Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HEK293 Cells; Humans; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred Strains; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oligopeptides; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2020 |
Neothalfine, a potent natural anti-tumor agent against metastatic colorectal cancer and its primary mechanism.
Topics: Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Structure-Activity Relationship | 2021 |
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Caco-2 Cells; Colorectal Neoplasms; Disease Models, Animal; Docetaxel; Female; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Micelles | 2021 |
CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Colorectal Neoplasms; Docetaxel; Drug Carriers; Endothelial Cells; Mice; Nanoparticles; Proto-Oncogene Proteins c-akt | 2023 |
Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Caco-2 Cells; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Colorectal Neoplasms; Cyclophosphamide; Docetaxel; Down-Regulation; Drug Synergism; Female; Fluorouracil; GRB2 Adaptor Protein; Humans; Insulin; Irinotecan; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplastic Cells, Circulating; Oxaliplatin | 2019 |
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve.
Topics: Animals; Antineoplastic Agents, Immunological; Cell Line, Tumor; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Female; Humans; Immune Checkpoint Inhibitors; Interleukin-15; Mice; Receptors, OX40; Recombinant Fusion Proteins; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Necrosis Factor Receptor Superfamily, Member 9; Vaccines, DNA; Xenograft Model Antitumor Assays | 2021 |
A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cyclodextrins; Docetaxel; Folic Acid; Mice; Nanoparticles; Polyethylene Glycols; RNA, Small Interfering | 2021 |
Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Benzofurans; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Molecular Structure; Receptor, ErbB-2; Stilbenes; Taxoids; Tumor Burden | 2017 |
Raman endoscopy for monitoring the anticancer drug treatment of colorectal tumors in live mice.
Topics: Animals; Antineoplastic Agents; Cisplatin; Colorectal Neoplasms; Docetaxel; Endoscopy; Fluorouracil; Mice; Mice, Inbred BALB C; Spectrum Analysis, Raman | 2017 |
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Phenylurea Compounds; Prednisone; Prostatic Neoplasms, Castration-Resistant; Pyridines; Quality of Life; Retrospective Studies; Taxoids; Treatment Outcome | 2017 |
Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Survival; Chitosan; Colorectal Neoplasms; Delayed-Action Preparations; Docetaxel; Drug Carriers; Drug Compounding; Drug Liberation; Dynamic Light Scattering; HT29 Cells; Humans; Injections, Intraperitoneal; Lactic Acid; Male; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Taxoids; Technology, Pharmaceutical | 2018 |
Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colon; Colorectal Neoplasms; Docetaxel; Drug Carriers; Female; Humans; Lipids; Melanoma; Mice; Mice, Inbred BALB C; Nanoparticles; Rectum; Taxoids | 2013 |
Intravital FRET imaging of tumor cell viability and mitosis during chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Colorectal Neoplasms; Docetaxel; Enzyme Activation; Fluorescence Resonance Energy Transfer; Humans; Mice; Mitosis; Taxoids | 2013 |
CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.
Topics: Animals; Antineoplastic Agents; Base Sequence; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Deoxycytidine; DNA Methylation; DNA Primers; Docetaxel; Female; Gemcitabine; Gene Silencing; Humans; Mice; Microsatellite Instability; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Taxoids; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2014 |
Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
Topics: Adenomatous Polyposis Coli; Animals; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; Docetaxel; Drug Resistance, Neoplasm; Epigenesis, Genetic; Eye Proteins; Female; Gene Silencing; HCT116 Cells; Heterografts; Humans; Male; Mice; Neoplasm Transplantation; Signal Transduction; Taxoids; Transcription Factors; Transforming Growth Factor beta; Wnt Proteins | 2013 |
Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxel; Drug Carriers; Lactic Acid; Male; Mice; Microspheres; Particle Size; Peritoneal Neoplasms; Poloxamer; Porosity; Taxoids; Xenograft Model Antitumor Assays | 2014 |
RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; DNA Methylation; Docetaxel; Epigenesis, Genetic; Female; G2 Phase Cell Cycle Checkpoints; Genes, p53; Humans; M Phase Cell Cycle Checkpoints; Male; Mice; Mice, Inbred BALB C; Middle Aged; Promoter Regions, Genetic; Signal Transduction; Taxoids; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2015 |
The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Docetaxel; Drug Synergism; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Immunohistochemistry; Mice; Positron-Emission Tomography; Taxoids; Xenograft Model Antitumor Assays | 2016 |
Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer.
Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cathelicidins; Cell Line, Tumor; Colorectal Neoplasms; DNA Fragmentation; Docetaxel; Fluorescent Antibody Technique; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intraperitoneal; Lactic Acid; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Peritoneal Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Polyesters; Polymers; Spectroscopy, Fourier Transform Infrared; Taxoids; Temperature; X-Ray Diffraction | 2015 |
Transcatheter arterial chemoembolization with docetaxel-loaded microspheres controls heavily pretreated unresectable liver metastases from colorectal cancer: a case study.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoembolization, Therapeutic; Colorectal Neoplasms; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Microspheres; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Taxoids | 2011 |
Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Survival; Colorectal Neoplasms; Docetaxel; Genes, p53; Growth Differentiation Factor 15; HCT116 Cells; HT29 Cells; Humans; Molecular Targeted Therapy; Sulindac; Taxoids; Tumor Suppressor Protein p53; Up-Regulation | 2011 |
Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxel; Drug Synergism; Herb-Drug Interactions; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Phytotherapy; Plant Extracts; RNA, Messenger; Stomach Neoplasms; Survivin; tau Proteins; Taxoids; Tubulin; Xanthones | 2012 |
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Calreticulin; Carcinoembryonic Antigen; Cell Line, Tumor; Colorectal Neoplasms; Cytotoxicity, Immunologic; Dendritic Cells; Docetaxel; eIF-2 Kinase; Female; HMGB1 Protein; Humans; Immunotherapy; Male; Mucin-1; Prostate-Specific Antigen; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering; T-Lymphocytes, Cytotoxic; Taxoids | 2013 |
In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Cisplatin; Colorectal Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; In Vitro Techniques; Irinotecan; Leucovorin; Male; Middle Aged; Mitomycin; Taxoids | 2005 |
Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colorectal Neoplasms; Docetaxel; Drug Carriers; Esophageal Neoplasms; Feasibility Studies; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasms; Polymerase Chain Reaction; Stomach Neoplasms; Taxoids; Telomerase; Transplantation, Heterologous; Vinblastine; Vinorelbine | 2006 |
Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antineoplastic Agents; Base Pair Mismatch; Carrier Proteins; Chromones; Cisplatin; Colorectal Neoplasms; DNA Repair; Docetaxel; Drug Resistance, Neoplasm; Humans; Inositol; Morpholines; MutL Protein Homolog 1; Nuclear Proteins; Organoplatinum Compounds; Oxaliplatin; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Taxoids; Tumor Cells, Cultured | 2006 |
[In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ascites; Camptothecin; Cell Survival; Colorectal Neoplasms; Docetaxel; Female; Humans; Injections, Intraperitoneal; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured | 2006 |
Highlights of the Eighth European Cancer Conference.
Topics: Amifostine; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Irinotecan; Neoplasms; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Taxoids; Vinblastine; Vinorelbine | 1995 |
Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Base Pair Mismatch; Breast Neoplasms; Carrier Proteins; Colorectal Neoplasms; Deoxycytidine; DNA Repair; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Epirubicin; Female; Gemcitabine; Humans; Intercalating Agents; Mitoxantrone; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |
Clinical trials of new anticancer agents in recent years in China.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Clinical Trials as Topic; Colorectal Neoplasms; Docetaxel; Female; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Taxoids; Vinblastine; Vinorelbine | 2002 |